BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8681306)

  • 1. Preclinical studies of chemotherapy and radiation therapy for pancreatic carcinoma.
    Robertson JM; Shewach DS; Lawrence TS
    Cancer; 1996 Aug; 78(3 Suppl):674-9. PubMed ID: 8681306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer.
    McGinn CJ; Lawrence TS; Zalupski MM
    Cancer; 2002 Aug; 95(4 Suppl):933-40. PubMed ID: 12209674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Concurrent chemoradiotherapy using full-dose gemcitabine for patients with unresectable pancreatic cancer].
    Yamazaki H; Nishiyama K; Koizumi M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2004 May; 64(4):216-9. PubMed ID: 15211883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New applications of gemcitabine and future directions in the management of pancreatic cancer.
    Abbruzzese JL
    Cancer; 2002 Aug; 95(4 Suppl):941-5. PubMed ID: 12209675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index.
    Crane CH; Wolff RA; Abbruzzese JL; Evans DB; Milas L; Mason K; Charnsangavej C; Pisters PW; Lee JE; Lenzi R; Lahoti S; Vauthey JN; Janjan NA
    Semin Oncol; 2001 Jun; 28(3 Suppl 10):25-33. PubMed ID: 11510031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pancreatic cancer--diagnostics and therapy].
    Schramm H
    Zentralbl Chir; 2003 May; 128(5):367. PubMed ID: 12813632
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemoradiotherapy with twice-weekly administration of low-dose gemcitabine for locally advanced pancreatic cancer.
    Igarashi H; Ito T; Kawabe K; Hisano T; Arita Y; Kaku T; Takayanagi R
    World J Gastroenterol; 2008 Sep; 14(34):5311-5. PubMed ID: 18785284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer -- feasible and effective].
    Wilkowski R; Thoma M; Heinemann V; Rau HG; Wagner A; Stoffregen C; Dühmke E
    Strahlenther Onkol; 2003 Feb; 179(2):78-86. PubMed ID: 12590317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity modulated radiation therapy and chemotherapy for locally advanced pancreatic cancer: results of feasibility study.
    Bai YR; Wu GH; Guo WJ; Wu XD; Yao Y; Chen Y; Zhou RH; Lu DQ
    World J Gastroenterol; 2003 Nov; 9(11):2561-4. PubMed ID: 14606097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined gemcitabine and radiotherapy].
    Mornex F
    Bull Cancer; 2002 Aug; 89 Spec No():S127-33. PubMed ID: 12449044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer.
    Joensuu TK; Kiviluoto T; Kärkkäinen P; Vento P; Kivisaari L; Tenhunen M; Westberg R; Elomaa I
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):444-52. PubMed ID: 15380578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's new in pancreatic cancer treatment?
    Fung MC; Sakata T
    J Hepatobiliary Pancreat Surg; 2002; 9(1):61-75. PubMed ID: 12021899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer.
    Taira K; Boku N; Fukutomi A; Onozawa Y; Hironaka S; Yoshino T; Yasui H; Yamazaki K; Taku K; Hashimoto T; Nishimura T
    J Gastroenterol; 2008; 43(11):875-80. PubMed ID: 19012041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Concomitant use of radiotherapy and gemcitabine: preclinical findings and clinical practice].
    Azria D; Coelho M; Larbouret C; Lemanski C; Serre A; Ychou M; Pèlegrin A; Dubois JB; Culine S
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S106-13. PubMed ID: 15679255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of gemcitabine hydrochloride in the treatment for pancreatic cancer].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1461-7. PubMed ID: 11681259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of full-dose gemcitabine with radiation therapy compared to 5-fluorouracil with radiation therapy for locally advanced pancreas cancer.
    Huang J; Robertson JM; Margolis J; Balaraman S; Gustafson G; Khilanani P; Nadeau L; Jury R; McIntosh B
    Radiother Oncol; 2011 May; 99(2):114-9. PubMed ID: 21621866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297.
    Berlin JD; Catalano P; Thomas JP; Kugler JW; Haller DG; Benson AB
    J Clin Oncol; 2002 Aug; 20(15):3270-5. PubMed ID: 12149301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gemcitabine: a new chemotherapy agent for solid cancers].
    Klastersky J; Awada A
    Rev Med Brux; 1997 Oct; 18(5):328-34. PubMed ID: 9441329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine plus radiotherapy for non-small cell lung cancer.
    Gregor A
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-39-S8-41. PubMed ID: 9207316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine).
    Fields MT; Eisbruch A; Normolle D; Orfali A; Davis MA; Pu AT; Lawrence TS
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):785-91. PubMed ID: 10837965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.